Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma
β Scribed by O. ERDEM; M. ERDEM; A. ERDEM; L. MEMIS; G. AKYOL
- Book ID
- 109086143
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 98 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Angiogenesis is a key process in tumour growth and metastasis, and microvessel density has been found to influence the prognosis of endometrial carcinoma patients. Less is known about regulators of angiogenesis. Studies of other tumour types have indicated that the density of tumourassociated macrop
## Abstract ## Background and Objectives To compare uterine leiomyosarcomas (LMS) and leiomyomas (LM) with normal myometrium in terms of microvessel density (MVD), and to correlate this parameter with vascular endothelial growth factor (VEGF) expression and clinical/pathological parameters. ## Me
## Abstract ## BACKGROUND. Caveolinβ1, which has been proposed as a candidate tumor suppressor, plays a regulatory role in several signaling pathways. The importance of caveolinβ1 in endothelial cells in angiogenesis has been confirmed. The clinicopathologic significance of caveolinβ1 expression a